Poster Spotlight Session 7: Prevention
Wednesday, December 6 • 5:30 p.m. – 6:30 p.m.  • Stars at Night Ballroom 3-4

Presentation: Exemestane and breast cancer prevention: how low can we go? Drug and biomarker tissue levels in a randomized presurgical trial on exemestane alternative dosing regimen

Davide Serrano, MD
European Institute of Oncology IRCCS,
Milan, Italy

What is your presentation about?
Breast cancer prevention medicine. We are looking at the minimal effective dose to balance efficacy and side effects.

What makes this topic important in 2023?
Developing more acceptable cancer prevention interventions is becoming very important.